Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer

Acta Oncologica

Volumn 49, Issue 1, 2010, Pages 57-62

  Derwinger, Kristoffer ^a   Kodeda, Karl ^a   Bexe Lindskog, Elinor ^a   Taflin, Helena ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION;

AGED; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS;

EID: 76649114026     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903334411     Document Type: Article

References (25)

1. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007;50:113-30.
2. UICC/AJCC. TNM classification of malignant tumors. 5th ed. Wiley-Liss, New York 1997.
3. Kehoe J, Khatri VP. Staging and prognosis of colon cancer. Surg Oncol Clin N Am 2006;15:129-46.
4. Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 2008;14:143-8.
5. Wang LM, Kevans D, Mulcahy H, O'Sullivan J, Fennelly D, Hyland J, et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol 2008.
6. SAP, Swedish Association of Pathology: KVAST. National quality guideline documents. Swedish.
7. Compton CC. Colorectal carcinoma: Diagnostic, prognostic, and molecular features. Mod Pathol 2003;16:376-88.
8. Compton CC. Optimal pathologic staging: Defining stage II disease. Clin Cancer Res 2007;13(22 Pt 2): 6862s-70s.
9. Mori T, Hirota T, Ohashi Y, Kodaira S. Significance of histologic type of primary lesion and metastatic lymph nodes as a prognostic factor in stage III colon cancer. Dis Colon Rectum 2006;49:982-92.
10. Derwinger K, Carlsson G, Gustavsson B. A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol 2008;34:771-5.
11. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
12. Blumberg D, Paty PB, Guillem JG, Picon AI, Minsky BD, Wong WD, et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 1999;42:881-5.
13. Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, et al. Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology 2005;52:1688-91.
14. Choi PW, Yu CS, Jang SJ, Jung SH, Kim HC, Kim JC. Risk factors for lymph node metastasis in submucosal invasive colorectal cancer. World J Surg 2008;32:2089-94.
15. Nascimbeni R, Burgart LJ Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002;45:200-6.
16. Yamamoto S, Watanabe M, Hasegawa H, Baba H, Yoshinare K, Shiraishi J, et al, The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology 2004;51:998-1000.
17. Glimelius B, Dahl O, Cedermark B, Jakobsen A, Bentzen SM, Starkhammar H, et al. Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol 2005;44:904-12.
18. Derwinger K, Carlsson G, Gustavsson B. Stage migration in colorectal cancer related to improved lymph node assessment. Eur J Surg Oncol 2007;33:849-53.
19. Turner J, Saclarides TJ. Transanal endoscopic microsurgery. Minerva Chir 2008;63:401-12.
20. Nascimbeni R, Nivatvongs S, Larson DR, Burgart LJ. Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum 2004;47:1773-9.
21. Doornebosch PG, Tollenaar RA, De Graaf EJ. Is the increasing role of Transanal Endoscopic Microsurgery in curation for T1 rectal cancer justified? A systematic review. Acta Oncol 2009;48:343-53.
22. Baatrup G, Endreseth BH, Isaksen V, Kjellmo A, Tveit KM, Nesbakken A. Preoperative staging and treatment options in T1 rectal adenocarcinoma. Acta Oncol 2009; 48:328-42.
23. Compton CC. Surgical pathology for the oncology patient in the age of standardization: Of margins, micrometastasis, and molecular markers. Semin Radiat Oncol 2003;13:382-8.
24. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979-94.
25. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 2005;48:1161-8.